Allograft replacement for infrarenal aortic graft infection: Early and late results in 179 patients

Journal of Vascular Surgery

Volumn 39, Issue 5, 2004, Pages 1009-1017

  Kieffer, Edouard ^a   Gomes, Dominique ^a   Chiche, Laurent ^a   Fléron, Marie Hélène ^a   Koskas, Fabien ^a   Bahnini, Amine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGRAFT; AORTA ANEURYSM; AORTA DILATATION; AORTA DISEASE; AORTA GRAFT; AORTOINTESTINAL FISTULA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYOPRESERVATION; EMERGENCY TREATMENT; FEMALE; GRAFT INFECTION; GRAFT OCCLUSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; SEPTIC SHOCK; SURGICAL MORTALITY; SURVIVAL RATE; THORACIC AORTA; THROMBOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 2342635167     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2003.12.040     Document Type: Article

References (50)

1. Oudot J, Beaconsfield P. Thrombosis of the aortic bifurcation treated by resection and homograft replacement. Arch Surg 1953;66:365-74.
2. Dubost C, Allary M, Oeconomos N. Resection of an aneurysm of the abdominal aorta: reestablishment of the continuity by a preserved human arterial graft, with results after five months. Arch Surg 1952;64: 405-8.
3. DeBakey ME, Creech O Jr. Occlusive disease of the aorta and its treatment by resection and homograft replacement. Ann Surg 1954; 140:290-310.
4. Szilagyi DE, Overhuise PR, Logrippo GA. Use of chemically sterilized arterial homografts. Clin Res Proc 1954;2:108-13.
5. Bahnini A, Ruotolo C, Koskas F, Kieffer E. In situ fresh allograft replacement of an infected aortic prosthetic graft: 18-month follow-up. J Vasc Surg 1991;14:98-102.
6. Kieffer E, Bahnini A, Koskas F, Ruotolo C, LeBlevec D, Plissonnier D. In situ allograft replacement of infected infrarenal aortic prosthetic grafts: results in 43 patients. J Vasc Surg 1993;17:349-56.
7. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 2000;32:451-61.
8. Yeager RA, Taylor LM, Moneta GL, Edwards JM, Nicoloff AD, McConnell DB, et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 1999;30:76-83.
9. Bacourt F, Koskas F, and Association Universitaire de Recherche en Chirurgie. Axillo-femoral bypass and aortic exclusion for vascular septic lesions: a multicenter retrospective study of 98 cases. Ann Vasc Surg 1992;6:119-26.
10. Ehrenfeld WK, Wilbur DG, Olcott CN, Stoney RJ. Autogenous tissue reconstruction in the management of infected prosthetic grafts. Surgery 1979;85:82-92.
11. Clagett GP, Valentine RJ, Hagino KT. Autogenous aortoiliac/femoral reconstruction from superficial femoral-popliteal veins: feasibility and durability. Am J Surg 1999;178:136-40.
12. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR, et al. In situ replacement of infected aortic grafts with rifampin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999;30:92-8.
13. Young RM, Cherry KY Jr, Davis PM, Gloviczki P, Bower TC, Panneton JM, et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg 1999;178:136-40.
14. Donaldson RM, Ross DM. Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation 1984;70(suppl 1):178-81.
15. Pagano D, Allen SM, Bonser RS. Homograft aortic valve and root replacement for severe destructive native or prosthetic endocarditis. Eur J Cardiothorac Surg 1994;8:173-6.
16. Moore WS, Swanson KJ, Campagna G, Bean B. The use of fresh tissue arterial substitutes in infected fields. J Surg Res 1975;18:229-33.
17. Snyder SA, Wheeler JR, Gregory RT, Gayle RG, Zukle PK. Freshly harvested cadaveric venous homografts as arterial conduits in infected fields. Surgery 1987;101:283-91.
18. Di Muzio PJ, Reilly LM, Stoney RJ. Redo aortic grafting after treatment of aortic graft infection. J Vasc Surg 1996;24:328-37.
19. Kieffer E, Gomes D, Plissonnier D, Koskas F, Bahnini A. Current use of allografts for infrarenal aortic graft infection. In: Yao JST, Pearce WH, editors. Modern vascular surgery. New York (NY): McGraw-Hill; 2000. 297-308.
20. Koskas F, Plissonnier D, Bahnini A, Ruotolo C, Kieffer E. In situ arterial allografting for aortoiliac graft infection: a 6-year experience. Cardiovasc Surg 1996;4:495-9.
21. Ruotolo C, Plissonnier D, Bahnini A, Koskas F, Kieffer E. In situ arterial allograft: a new treatment for aortic prosthetic infection. Eur J Vasc Endovasc Surg 1997;14(suppl A):102-7.
22. Chiesa R, Astore D, Piccolo G, Melissano G, Jannello A, Frigerio D, et al. Fresh and cryopreserved arterial homografts in the treatment of prosthetic graft infections: experience of the Italian Collaborative Vascular Homograft Group. Ann Vasc Surg 1998;12:457-62.
23. Desgranges P, Beaujan F, Brunet S, Cavillon A, Qvarfordt P, Mellière D, et al. Cryopreserved arterial allografts used for the treatment of infected vascular grafts. Ann Vasc Surg 1998;12:583-8.
24. Locati P, Novati C, Socrate AM, Costantini E, Moriacchi E, Piazzalunga G, et al. The use of arterial allografts in aortic graft infections: a three year experience in eighteen patients. J Cardiovasc Surg 1998;89: 735-41.
25. Lehalle B, Geschier C, Fieve G, Stoltz JF. Early rupture and degeneration of cryopreserved arterial allografts. J Vasc Surg 1997;25:751-2.
26. Nevelsteen A, Feryn T, Lacroix H, Suy R, Goffin Y. Experience with cryopreserved arterial allografts in the treatment of prosthetic graft infections. Cardiovasc Surg 1998;6:378-83.
27. Noel AA, Gloviczki P, Cherry KJ, Safi H, Goldstone J, Morash MD, et al. Abdominal aortic reconstruction in infected fields: early results of the United States Cryopreserved Aortic Allograft Registry. J Vasc Surg 2002;35;847-52.
28. Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H, Limet R, et al. Use of cryopreserved arterial homografts for management of infected prosthetic grafts: a multicentric study. Ann Vasc Surg 2000;14:602-7.
29. Wassenaar C, Wijsmuller EG, Van Herwerden LA, Aghai Z, Van Tricht CLJ, Bos E. Cracks in cryopreserved aortic allografts and rapid thawing. Ann Thorac Surg 1995;60:S165-7.
30. Boren CH, Roon AJ, Moore WS. Maintenance of viable arterial allografts by cryopreservation. Surgery 1978;83:382-91.
31. Motomura N, Imakita M, Yutani C, Takamoto S, Kotoh Y, Tsuji T, et al. Histologic modification by cryopreservation in rat aortic allografts. Ann Thorac Surg 1995;60:S168-71.
32. Neves JP, Gulbenkian S, Ramos T, Martins AP, Caldas MC, Mascarenhas R, et al. Mechanisms underlying degeneration of cryopreserved vascular homografts. J Thorac Cardiovasc Surg 1997;113:1014-21.
33. Vischjager M, Van Gulik TM, Van Marie J, Pfaffendorf M, Jacobs MJHM. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. J Vasc Surg 1996;24:876-82.
34. Camiade C, Goldschmidt P, Koskas F, Ricco J-B, Jarraya M, Gerota J, et al. Optimization of the resistance of arterial allografts to infection: comparative study with synthetic prostheses. Ann Vasc Surg 2001;15: 186-96.
35. Knosalla C, Goeau-Brissonnière O, Leflon V, Bruneval P, Eugene M, Pechere JC, et al. Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg 1998;27:689-98.
36. Koskas F, Goeau-Brissonnière O, Nicolas MH, Bacourt F, Kieffer E. Arteries from human beings are less infectible by Staphylococcus aureus than polytetrafluoroethylene in an aortic dog model. J Vasc Surg 1996;23:472-6.
37. Lesèche G, Castier Y, Petit MD, Bertrand P, Kitzis M, Mussot S, et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001;34:616-22.
38. Petersen MJ, Abbott WM, H'Doubler PB Jr, L'Italien GJ, Hoppel BE, Rosen BR, et al. Hemodynamics and aneurysm development in vascular allografts. J Vasc Surg 1993;18:955-64.
39. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414-24.
40. Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM. Immunosuppressive treatment of aortic allografts. J Vasc Surg 1998;7: 82-92.
41. Halpert B, DeBakey ME, Jordan GL, Henly WS. The fate of homografts and prostheses of the human aorta. Surg Gynecol Obstet 1960;111:659-74.
42. Humphries AW, Hawk WA, De Wolfe VG, LeFevre FA. Clinicopathologic observations on the fate of arterial freeze-dried homografts. Surgery 1959;45:59-71.
43. Knox WG, Miller RE. Long-term appraisal of aortic and arterial homografts implanted in years 1954-1957. Ann Surg 1970;172: 1076-8.
44. Meade JW, Linton RR, Darling RC, Menendez CV. Arterial homografts: a long-term clinical follow-up. Arch Surg 1966;93:392-9.
45. Szilagyi DE, McDonald RT, Smith RF, Whitcomb JG. Biologic fate of human arterial homografts. Arch Surg 1957;75:506-29.
46. Szilagyi DE, Rodriguez FJ, Smith RF, Elliott JP. Late fate of arterial allografts: observations 6 to 15 years after implantation. Arch Surg 1970;101:721-33.
47. Allaire E, Guettier C, Bruneval P, Plissonnier D, Michel JB. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994;19:446-56.
48. Julia PL, Sapoval M, Diemont F, Chemla E, Gaux JC, Fabiani JN. Endovascular repair of aortic allograft aneurysmal degeneration: a case report. J Vasc Surg 2000;32:1222-4.
49. Giglio JS, Ollerenshaw TD, Dawson PE, Black KS, Abbott WM. Cryopreservation prevents arterial allograft dilatation. Ann Vasc Surg 2002;16:762-7.
50. Dumont CE, Plissonnier D, Guettier C, Michel JB. Effects of glutaraldehyde on experimental arterial iso and allografts in rats. J Surg Res 1993;54:61-9.